Daniel Dornbusch

Daniel Dornbusch is the Chief Executive Officer and a Board Member at Excision BioTherapeutics, where he has been instrumental in driving the company's mission in the biotechnology sector. With over 20 years of experience, he has held various leadership roles across large pharmaceutical companies, small biotechnology firms, and diagnostics organizations.

Professional Background

• Current Role: CEO and Board Member at Excision BioTherapeutics.
• Previous Experience:
  • Founder and CEO of Acteris, an immuno-oncology company.
  • Chief Commercial Officer at Nodality, focusing on therapeutic development in immunology and oncology.
  • Held significant positions at Novartis, including Commercial Director for the Western U.S. and Latin America in the Diagnostics Division.
  • Worked in business development at Cerimon Pharmaceuticals and led oncology strategy at AmerisourceBergen.

Education

• Bachelor's Degree: B.A. in Biology and English from Cornell University.
• Master's Degrees: M.S. from Tufts University School of Medicine and Emerson College.
• MBA: Harvard Business School.

Dornbusch's extensive background combines expertise in business development, marketing, sales, and product development, making him a prominent figure in the biotechnology industry.123